CompletedPhase 4

Regenerative Surgical Treatment of Peri-implantitis

Sweden31 participantsStarted 2008-12

Plain-language summary

The purpose of the study is to evaluate if surgical treatment of peri-implantitis with enamel matrix derivative (Emdogain®, EMD) will have an additional effect on the healing outcome, changes in the peri-implant microflora and on the inflammatory response in the periimplant pocket at 12 months.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * peri-implant angular bone loss ≥3 mm, measured at radiographs * deep pocket ≥5 mm combined with bleeding and/or pus Exclusion Criteria: * individuals with uncontrolled diabetes (HbA1c \> 7,0%) * individuals where prophylaxis of antibiotic is indicated * medication with prednisolon or other anti-inflammatory drug * medication with gingival hyperplasia known as a side effect * systemic antibiotic intake the last 3 months

What they're measuring

Changes in marginal bone level at dental implant

Timeframe: 12 months

Trial details

NCT IDNCT02500654

SponsorCatrine Isehed

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-01

View on ClinicalTrials.gov More Failure of Dental Implant Due to Infection trials